tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
US Market
ORMP
Oramed Pharm
RESEARCH TOOLSreports
Want to see ORMP full AI Analyst Report?

Oramed Pharm (ORMP) Income Statement

529 Followers

Oramed Pharm Income Statement

Last quarter (Q4 2025), Oramed Pharm's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Oramed Pharm's net income was $21.28M. See Oramed Pharm’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Sep 23Dec 22Aug 21
Total Revenue
$ 2.00M$ 0.00$ 1.34M$ 2.70M$ 2.70M
Gross Profit
$ 13.00K$ -193.00K$ 1.34M$ 2.70M$ 2.70M
Operating Expenses
$ 15.10M$ 12.78M$ 17.11M$ 43.30M$ 26.93M
Depreciation and Amortization
$ 0.00$ 193.00K$ 196.00K$ 3.62M$ 77.00K
EBITDA
$ -15.09M$ -14.87M$ 7.32M$ -36.98M$ -25.04M
Operating Income
$ -15.09M$ -12.78M$ -15.77M$ -40.60M$ -24.22M
Other Income/Expenses
$ 90.41M$ -3.14M$ 20.86M$ 2.93M$ 893.00K
Pretax Income
$ 75.32M$ -15.92M$ 5.09M$ -37.66M$ -22.99M
Net Income
$ 75.32M$ -19.10M$ 5.53M$ -37.76M$ -22.24M
Per Share Metrics
Basic EPS
$ 1.53$ -0.47$ 0.14$ -0.97$ -0.78
Diluted EPS
$ 1.50$ -0.47$ 0.14$ -0.97$ -0.78
Weighted Average Shares Outstanding
 41.40M 40.83M 40.32M 39.00M 28.47M
Weighted Average Shares Outstanding (Diluted)
 42.42M 40.83M 40.57M 39.00M 28.47M
Currency in USD

Oramed Pharm Earnings and Revenue History